Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.092,34
-0,15%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Javelin Pharmaceuticals (JAV) Javelin Pharmaceuticals (JAV) Notizie

JAV

Javelin Pharmaceuticals (JAV)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:JAV
DataOraFonteTitoloSimboloCompagnia
07/07/201012:00Edgar (US Regulatory)Notice of Effectiveness (EFFECT)AMEX:JAVJavelin Pharmaceuticals
06/07/201019:14Edgar (US Regulatory)(25-NSE)AMEX:JAVJavelin Pharmaceuticals
02/07/201022:39Edgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)AMEX:JAVJavelin Pharmaceuticals
02/07/201022:24Edgar (US Regulatory)Post-Effective Amendment to Registration Statement (POS AM)AMEX:JAVJavelin Pharmaceuticals
02/07/201021:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:JAVJavelin Pharmaceuticals
02/07/201021:24Edgar (US Regulatory)Current report filing (8-K)AMEX:JAVJavelin Pharmaceuticals
01/07/201023:20Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)AMEX:JAVJavelin Pharmaceuticals
01/07/201020:59Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)AMEX:JAVJavelin Pharmaceuticals
01/07/201014:05Business WireJavelin Pharmaceuticals, Inc. Announces Successful Completion of Tender Offer for Its Common Stock by Hospira, Inc.AMEX:JAVJavelin Pharmaceuticals
30/06/201012:50GlobeNewswire Inc.Javelin Pharmaceuticals Inc. is Today's Focus Stock on MicroStockProfit.comAMEX:JAVJavelin Pharmaceuticals
22/06/201000:23Dow Jones News2nd UPDATE: Business Wire CEO: Reported Fake Release To FBIAMEX:JAVJavelin Pharmaceuticals
21/06/201022:08Dow Jones NewsUPDATE: Business Wire CEO: Reported Fake Release To FBIAMEX:JAVJavelin Pharmaceuticals
21/06/201016:33Dow Jones NewsBusiness Wire CEO: Reported Fake Release To FBIAMEX:JAVJavelin Pharmaceuticals
21/06/201014:30Business WireNews Release Service Inadvertently Issues Hoax Press Release Identifying Javelin Pharmaceuticals as IssuerAMEX:JAVJavelin Pharmaceuticals
11/06/201015:00Business WireJavelin Receives $2 Million Loan from HospiraAMEX:JAVJavelin Pharmaceuticals
07/06/201014:30Business WireJavelin Receives Notice from Hospira of Funding of LoanAMEX:JAVJavelin Pharmaceuticals
04/06/201022:05Business WireJavelin Receives Notice From NYSE Amex LLC of Non-ComplianceAMEX:JAVJavelin Pharmaceuticals
03/06/201013:30Business WireJavelin Commences Litigation against Hospira & Discus Acquisition Corporation, Asserts Hospira is in Breach of Merger Agreeme...AMEX:JAVJavelin Pharmaceuticals
26/05/201023:23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)AMEX:JAVJavelin Pharmaceuticals
24/05/201015:05Business WireJavelin Pharmaceuticals, Inc. Provides Update to Dyloject™ UK Supply ChainAMEX:JAVJavelin Pharmaceuticals
19/05/201014:59Business WireJavelin Pharmaceuticals, Inc. Comments on Tender Offer Extension by HospiraAMEX:JAVJavelin Pharmaceuticals
10/05/201022:16Business WireJavelin Pharmaceuticals, Inc. Reports First Quarter 2010 ResultsAMEX:JAVJavelin Pharmaceuticals
10/05/201021:01Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:JAVJavelin Pharmaceuticals
22/04/201012:02Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)AMEX:JAVJavelin Pharmaceuticals
21/04/201023:06Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)AMEX:JAVJavelin Pharmaceuticals
19/04/201023:20Business WireKendall Law Group Investigating Javelin Pharmaceuticals, Inc. Merger AgreementAMEX:JAVJavelin Pharmaceuticals
19/04/201022:44Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)AMEX:JAVJavelin Pharmaceuticals
19/04/201018:47Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)AMEX:JAVJavelin Pharmaceuticals
19/04/201015:49Dow Jones NewsJavelin, Myriad Officially Terminate Buyout DealAMEX:JAVJavelin Pharmaceuticals
19/04/201014:50Business WireJavelin Pharmaceuticals Announces Termination of Merger Agreement with Myriad Pharmaceuticals, Cancels Special Meeting of Sto...AMEX:JAVJavelin Pharmaceuticals
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:JAV

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
BAMI
Banco BPM
BIT
RACE
Ferrari NV
BIT
SPM
Saipem
BIT
G
Generali
BIT
NEXI
Nexi S.p.A
BIT
TIT
Telecom Italia
BIT
PST
Poste Italiane S.p.a
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network